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ABSTRACT
Aim: The present study was performed in order to differentiate E. histolytica and E. dispar in children from Gorgan city,
using a PCR method.
Background: Differential detection of two morphologically indistinguishable protozoan parasites Entamoeba 
histolytica and E. dispar has a great clinical and epidemiological importance because of potential invasive pathogenic E. 
histolytica and non-invasive parasite E. dispar. 
Patients and methods: One hundred and five dysentery samples were collected from children hospitalized in Taleghani
hospital in Gorgan city. The fecal specimens were examined by light microscopy (10X then 40X) to distinguish 
Entamoeba complex. A single round PCR amplifying partial small-subunit rRNA gene was performed on positive 
microscopy samples to differentiate E. histolytica/ E. dispar and E. moshkovskii from each other. 
Results: Twenty-five specimens (23.8%) were positive for Enramoeba complex in direct microscopic examination. PCR 
using positive controls indicated E. histolytica and E. dispar in two (2/25, 8%) and three (3/25, 12%) samples, respectively.  
Conclusion: There is a warrant to performing molecular diagnosis for stool examination at least in hospitalized children 
in order to prevent incorrect reports from laboratories and consequently mistreating by physicians.
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Introduction  
Amoebiasis is still mentioned as one of the main 
health problems in tropical and subtropical regions 
(1). The true prevalence of infection caused by
Entamoeba histolytica is unknown for most areas 
of the world (2). 
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E. histolytica causes widespread mortality and 
morbidity worldwide through diarrheal disease 
and abscess establishment in parenchymal tissues
such as liver, lung, and brain (3). In contrast, other 
amoebae that infect humans include E. dispar, E.
moshkovskii, E. coli, E. hartmanni, and Endolimax 
nana, have been considered nonpathogenic (4). 
E. histolytica, E. dispar, and E. moshkovskii are
morphologically indistinguishable but are different 
biochemically and genetically. Although E. 
histolytica is recognized as a pathogen, the ability 
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of the other two species to cause disease is unclear
(5). It is also worthy to note that until recently the 
differentiation of E. histolytica from the non-
pathogenic amebic species was not possible (6, 7).
The epidemiology of E. histolytica in Iran is 
poorly understood. Fortunately, several studies 
over the last decade have begun to evaluate the 
prevalence or incidence of E. histolytica in 
specific populations of Iran, these studies were 
utilized different molecular methods in order to 
differentiate the non-pathogenic E. dispar or E. 
moshkovskii from the pathogenic E. histolytica (8­
16). In this study, we used the well-characterized
diagnostic tests (single round PCR) to examine the 
prevalence of E. histolytica, E. dispar and E. 
moshkovskii infections in children with dysentery
in Golestan province, Iran. 
Patients and Methods 
From January 2010 to September 2012, 105
dysentery samples were collected from children
hospitalized in Taleghani hospital in Gorgan city, 
the capital of Golestan Province, located in
northern Iran and south east of Caspian sea. Socio­
demographic and clinical data were collected from 
the child’s parents and medical records. 
Stool specimens were screened microscopically
using direct slide smear for the presence of
Entamoeba spp. (13). Genomic DNA was 
extracted directly from stool specimens were
microscopically positive by using a QIAamp® 
DNA Stool Kit (QIAGEN) according to the 
manufacturer's instructions. The extracted DNA
was stored at -20°C until PCR amplification. A 
single–round PCR reaction and primers sets
amplifying partial small-subunit rRNA gene were 
used as described previously (13, 17, 18). The 
sequence of the forward primer used was 
conserved in all three Entamoeba spp., but the 
reverse primers were specific for apiece. The
expected PCR products from E. histolytica, E. 
dispar and E. moshkovskii were 166 bp, 752 bp,
and 580 bp, respectively (17). 
Amplification of each species–specific DNA 
fragment started with an initial denaturation at 94°C 
for 3 min, followed by 30 cycles of 94°C for 1 min,
58°C for 1 min, and 72°C for 1 min, with a final 
extension at 72°C for 7 min (14). PCR products were
visualized with ethidium bromide staining after 
electrophoresis on 1.5% agarose gels. DNA isolated
from axenically grown E. histolytica KU2, E. dispar
AS 16 IR and E. moshkovskii Laredo (ATCC
accession no. 300 42) (13) were used as positive 
controls. Medical Research Ethics Committee of 
Golestan University of Medical Sciences approved 
the study.
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Figure 1. Agarose gel electrophoresis of Entamoeba
species using single–round PCR. Lanes 2-3: E.
histolytica – positive isolates; Lane 5-7: E. dispar – 
positive isolates; Lanes 1, 4 and 8: E. histolytica , E. 
dispar  and E. moshkovskii positive controls, 
respectively. N: Negative control. M: 100 bp ladder 
DNA size marker 
Results 
Out of the 105 children with dysentery, 25
(23.8%) cases were infected with E. histolytica/E.
dispar/E. moshkovskii complex. After DNA 
extraction, the single-round PCR was carried out to 
differentiate the Entamoeba spp. of 25 samples that 













































166 Discrimination of Entamoeba Spp. in children with dysentery
were microscopically positive. Three (12%) E. 
dispar and 2 (8%) E. histolytica were detected by 
PCR (Figure 1). Infection of E. moshkovskii was not 
observed in this study. 
Amplification produced fragments of 166bp,
752bp and 580bp corresponding to the expected 
products from E. histolytica, E. dispar and E.
moshkovskii, respectively. 
Discussion 
Infection with E. histolytica is a severe health
problem in many tropical and subtropical areas of 
the world, especially in developing countries such 
as Iran (19, 20). 
It is now known that most of human cases of
infection with E. histolytica/E. dispar are actually 
E. dispar. E. dispar is non-pathogenic, and 
requires no treatment. Because of this, differential 
diagnosis of the pathogen E. histolytica from the 
commensally E. dispar is of the utmost
importance (21). 
Most epidemiological studies for E. histolytica
infection were performed before the acceptance of
E. histolytica/E. dispar and E. moshkovskii as 
distinct species. There is a clear need to perform 
new epidemiological studies to distinguish these 
three species of Entamoeba and to find true
prevalence of E. histolytica species (14).
The results of this study clearly show that, 
microscopy is not a sensitive and reliable 
technique for diagnosing amebic dysentery as well 
as differentiation of E. histolytica from E. dispar
and E. moshkovskii, because most amebic
infections in this population were due to other 
nonpathogenic Entamoeba species (17). In a 
previous study in Gonbad city 16 (69.5%) from 23
microscopic positive isolates for Entamoeba
species were amplified in PCR as E. dispar, none 
of the isolates (0%) revealed as E. histolytica and
the seven isolates were not amplified in PCR. The 
higher prevalence of E. dispar is in concordance 
with our study (10). The 20 negative PCR isolates 
(30.43%) with both two sets of E. histolytica and 
E. dispar primers in this study might be due to
lack of enough DNA template, PCR error or 
misdiagnosis with some other Entamoeba species.
However, this conjecture should be confirmed by
the further development of molecular diagnosis for
other nonpathogenic Entamoeba species
commonly found in humans, such as E. coli and E.
hartmanni (17).
While the isolates were achieved typically from 
patients who suffered from dysentery, we found 
no E. histolytica among the isolates and observed
no correlation between the presences of
Entamoeba spp. and clinical symptoms, such as 
abdominal pain, diarrhea or nausea. It may be that
the clinical symptoms of some patients were due 
to viral or bacterial pathogens not detected by the 
tests that had been run as in a valid study,
Kermani et al. showed that Enteroaggregative 
Escherichia coli was the most prevalent pathogen 
in both persistent and acute diarrhea children 
admitted to a pediatric hospital (22).
In conclusion, the finding of our study 
emphasis to perform molecular diagnosis for stool 
examination at least in hospitalized children in 
order to prevent incorrect results from medical
laboratories and consequently mistreating by
physicians. 
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